Abstract
Objectives
To evaluate the efficacy of selective arterial embolization (SAE) of angiomyolipomas based on the percentage volume reduction after embolization and to identify predictive factors of volume decrease.
Methods
Patients receiving prophylactic SAE of renal angiomyolipomas were included retrospectively over 3 years. The volume change after SAE and haemorrhagic or surgical events were recorded. Initial tumour volume, percentage tumour fat content, mean tumour density, embolic agent used, number of angiomyolipomas and tuberous sclerosis disease were evaluated as predictive factors of volume decrease.
Results
A total of 19 patients with 39 angiomyolipomas were included with median follow-up of 28 months (interquartile range 21–37 months). All treatments were technically successful (92 % primary and 8 % secondary). No distal bleeding or any increase in size or surgical nephrectomy after SAE was recorded. Mean volume reduction was 72 % (±24 %). Volumes before SAE (R 2 = 0.276; p = 0.001), percentage fat content (R 2 = 0.612; p < 0.0001) and mean angiomyolipoma density (R 2 = 0.536; p < 0.0001) were identified as predictive factors of volume decrease. In multivariate regression, only percentage fat content influenced volume decreases.
Conclusions
SAE is an efficient treatment for angiomyolipoma devascularisation and volume reduction. A significant reduction of volume is modulated by the initial volume and tissue composition of the tumour.
Key Points
• Selective arterial embolization is effective for angiomyolipoma devascularisation and volume reduction
• Volume reduction depends of initial volume and tissue composition of the tumour
• Selective arterial embolization is a low radiation treatment
Similar content being viewed by others
Abbreviations
- HU:
-
Hounsfield unit
- PES:
-
post-embolization syndrome
- SAE:
-
selective arterial embolization
- TS:
-
tuberous sclerosis
References
Hajdu SI, Foote FW Jr (1969) Angiomyolipoma of the kidney: report of 27 cases and review of the literature. J Urol 102:396–401
Oesterling JE, Fishman EK, Goldman SM, Marshall FF (1986) The management of renal angiomyolipoma. J Urol 135:1121–1124
Zhang JQ, Fielding JR, Zou KH (2002) Etiology of spontaneous perirenal hemorrhage: a meta-analysis. J Urol 167:1593–1596
De Luca S, Terrone C, Rossetti SR (1999) Management of renal angiomyolipoma: a report of 53 cases. BJU Int 83:215–218
Steiner MS, Goldman SM, Fishman EK, Marshall FF (1993) The natural history of renal angiomyolipoma. J Urol 150:1782–1786
Ramon J, Rimon U, Garniek A et al (2009) Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol 55:1155–1161
Van Baal JG, Smits NJ, Keeman JN et al (1994) The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol 152:35–38
Stoica G, Kheir C, Schöenig A et al (2011) Preventive and emergency embolization of angiomyolipomas: our experience. Prog Urol 21:514–520
Chang Y-H, Wang L-J, Chuang C-K et al (2007) The efficacy and outcomes of urgent superselective transcatheter arterial embolization of patients with ruptured renal angiomyolipomas. J Trauma 62:1487–1490
Pappas P, Leonardou P, Papadoukakis S et al (2006) Urgent superselective segmental renal artery embolization in the treatment of life-threatening renal hemorrhage. Urol Int 77:34–41
Planché O, Correas J-M, Mader B et al (2011) Prophylactic embolization of renal angiomyolipomas: evaluation of therapeutic response using CT 3D volume calculation and density histograms. J Vasc Interv Radiol JVIR 22:1388–1395
Williams JM, Racadio JM, Johnson ND et al (2006) Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am J Kidney Dis 47:95–102
Chick CM, Tan B-S, Cheng C et al (2010) Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int 105:390–394
Tillou X, Boutemy F, Remond A, Petit J (2010) Contribution of curative and preventive embolization for renal angiomyolipomas treatment. Prog Urol 20:627–632
Kothary N, Soulen MC, Clark TWI et al (2005) Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol JVIR 16:45–50
Dabbeche C, Chaker M, Chemali R et al (2006) Role of embolization in renal angiomyolipomas. J Radiol 87:1859–1867
Lenton J, Kessel D, Watkinson AF (2008) Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin Radiol 63:864–870
Markel G, Cohen-Sinai T, Besser MJ et al (2009) Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma. Anticancer Res 29:145–154
Chatziioannou A, Gargas D, Malagari K et al (2012) Transcatheter arterial embolization as therapy of renal angiomyolipomas: the evolution in 15 years of experience. Eur J Radiol 81:2308–2312
Patatas K, Robinson GJ, Ettles DF, Lakshminarayan R (2013) Patterns of renal angiomyolipoma regression post embolisation on medium- to long-term follow-up. Br J Radiol 86:20120633
Chan CK, Yu S, Yip S, Lee P (2011) The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma. Urology 77:642–648
Lee S-Y, Hsu H-H, Chen Y-C et al (2009) Evaluation of renal function of angiomyolipoma patients after selective transcatheter arterial embolization. Am J Med Sci 337:103–108
Sapoval M, Pellerin O, Rehel J-L et al (2010) Uterine artery embolization for leiomyomata: optimization of the radiation dose to the patient using a flat-panel detector angiographic suite. Cardiovasc Intervent Radiol 33:949–954
Yamakado K, Tanaka N, Nakagawa T et al (2002) Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 225:78–82
Ewalt DH, Diamond N, Rees C et al (2005) Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J Urol 174:1764–1766
Lee W, Kim TS, Chung JW et al (1998) Renal angiomyolipoma: embolotherapy with a mixture of alcohol and iodized oil. J Vasc Interv Radiol JVIR 9:255–261
Han YM, Kim JK, Roh BS et al (1997) Renal angiomyolipoma: selective arterial embolization–effectiveness and changes in angiomyogenic components in long-term follow-up. Radiology 204:65–70
Nelson CP, Sanda MG (2002) Contemporary diagnosis and management of renal angiomyolipoma. J Urol 168:1315–1325
Simmons JL, Hussain SA, Riley P, Wallace DMA (2003) Management of renal angiomyolipoma in patients with tuberous sclerosis complex. Oncol Rep 10:237–241
Lemaitre L, Robert Y, Dubrulle F et al (1995) Renal angiomyolipoma: growth followed up with CT and/or US. Radiology 197:598–602
Acknowledgments
The authors thank Pippa McKelvie-Sebileau for medical editorial services. The scientific guarantor of this publication is Grenier Nicolas. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors has significant statistical expertise. Institutional review board approval was obtained. Written informed consent was waived by the institutional review board because of the retrospective nature of the study. No study subjects or cohorts have been previously reported. Methodology: retrospective, diagnostic or prognostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hocquelet, A., Cornelis, F., Le Bras, Y. et al. Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease. Eur Radiol 24, 1785–1793 (2014). https://doi.org/10.1007/s00330-014-3244-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-014-3244-4